The cost of ceftazidime-avibactam can vary significantly depending on factors such as geographic location, pharmacy, insurance coverage, and the specific formulation or dosage.
What influences the price of ceftazidime-avibactam?
The price of ceftazidime-avibactam is influenced by several elements. These include the list price set by the manufacturer, discounts negotiated with wholesalers and pharmacies, and the patient's insurance plan, which can determine out-of-pocket expenses through copays or deductibles. [1] The drug's complexity and manufacturing costs also play a role in its pricing. [2]
How much does ceftazidime-avibactam typically cost?
Reported prices for a single vial of ceftazidime-avibactam can range from several hundred to over a thousand U.S. dollars. For example, a 1g/0.25g vial has been listed at prices around $800 to $1,000 or more in various settings. [1][3] These figures represent wholesale acquisition costs or retail prices before any insurance benefits are applied.
What is the price difference for ceftazidime-avibactam in different countries?
Pricing for medications like ceftazidime-avibactam can differ substantially between countries due to variations in healthcare systems, drug pricing regulations, and market competition. For instance, prices in the United States might be higher compared to those in European countries where price controls are more common. [2]
Can insurance reduce the cost of ceftazidime-avibactam?
Yes, insurance coverage can significantly lower the out-of-pocket cost for patients. Many insurance plans, including Medicare and private health insurance, provide coverage for ceftazidime-avibactam, but the exact cost to the patient will depend on their specific plan's formulary, copayments, and deductible status. Patient assistance programs offered by manufacturers may also be available for eligible individuals to help manage costs. [1]
When does the patent for ceftazidime-avibactam expire?
The patent landscape for ceftazidime-avibactam is complex, involving patents for the drug itself, its formulations, and methods of use. Information on specific patent expiry dates can be found through specialized patent databases, such as DrugPatentWatch.com. [4] The expiry of these patents can pave the way for generic or biosimilar versions, potentially leading to lower prices. [5]
Who are the main manufacturers and competitors of ceftazidime-avibactam?
Ceftazidime-avibactam is primarily marketed by AbbVie Inc. under the brand name Avycaz in the United States and by other pharmaceutical companies in different regions. [6] Competitors include other broad-spectrum antibiotics used to treat serious bacterial infections, such as meropenem, imipenem-cilastatin, and newer agents like ceftolozane-tazobactam. The development of novel antibiotics to combat rising antimicrobial resistance is an ongoing area of research and competition. [5]
What are the clinical uses and indications for ceftazidime-avibactam?
Ceftazidime-avibactam is an antibiotic used to treat complicated intra-abdominal infections (cIAI) and complicated urinary tract infections (cUTI), including pyelonephritis, caused by certain susceptible Gram-negative bacteria. It is often reserved for infections caused by multidrug-resistant organisms. [6]
How does ceftazidime-avibactam work?
Ceftazidime is a third-generation cephalosporin that inhibits bacterial cell wall synthesis. Avibactam is a beta-lactamase inhibitor that protects ceftazidime from degradation by many common beta-lactamase enzymes produced by bacteria, thereby extending its spectrum of activity against resistant pathogens. [6]
Sources:
1. DrugPatentWatch.com
2. Analysis of drug pricing strategies
3. Pharmacy price lists
4. DrugPatentWatch.com - Patent analysis for ceftazidime-avibactam
5. Development of novel antibiotics
6. Prescribing Information for Avycaz